4basebio PLC (LON:4BB – Get Free Report)’s stock price passed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of GBX 520.03 and traded as low as GBX 518. 4basebio shares last traded at GBX 518, with a volume of 1,065 shares trading hands.
4basebio Price Performance
The company has a 50-day moving average of GBX 528.88 and a 200-day moving average of GBX 520.03. The company has a debt-to-equity ratio of 201.47, a quick ratio of 3.52 and a current ratio of 2.73. The firm has a market capitalization of £80.21 million, a price-to-earnings ratio of -4.47 and a beta of 1.09.
4basebio (LON:4BB – Get Free Report) last announced its earnings results on Monday, September 28th. The company reported GBX (0.57) EPS for the quarter. As a group, research analysts anticipate that 4basebio PLC will post -3.43 EPS for the current fiscal year.
About 4basebio
4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients. Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients. These products and technologies are also available for customers and partners with whom we endeavor to combine our capabilities and know-how to develop gene therapy solutions for clinical development and commercialisation.
Recommended Stories
- Five stocks we like better than 4basebio
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for 4basebio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 4basebio and related companies with MarketBeat.com's FREE daily email newsletter.
